We are a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Through our acquisition of SynthRx, Inc. in 2011, we acquired our Membrane Adhesion & Sealant Technology (MAST) platform, which includes proprietary poloxamer-related data and know-how derived from over two decades of clinical, nonclinical and manufacturing experience, and we are leveraging the MAST platform to develop MST-188 for diseases and conditions characterized by microcirculatory insufficiency.
Company Details
- Employees
- 5
- Founded
- -
- Phone
- (858)794-4956
- in****@****era.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- masttherapeutics.com
Mast Therapeutics, Inc. Questions
Mast Therapeutics, Inc.'s helpline number is (858)794-4956
Mast Therapeutics, Inc.'s website is masttherapeutics.com
Mast Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/adventrx-pharmaceuticals
Mast Therapeutics, Inc. has
5 employees.
View email and phone details for 5
employees at Mast Therapeutics, Inc..
Mast Therapeutics, Inc.'s industry is
Biotechnology Research
Mast Therapeutics, Inc.'s top competitors are
Pacira Biosciences, Inc.,
Savara Inc.,
Mast Health,
Nanocor Therapeutics, Inc.,
Kura Oncology, Inc.,
Cambria Biosciences,
Eragen Biosciences,
Hepregen Corporation,
Activx Biosciences,
Acadia Pharmaceuticals Inc..
Mast Therapeutics, Inc.'s support email address is info@mastthera.com
Mast Therapeutics, Inc.'s categories are Biotechnology Research
Mast Therapeutics, Inc.'s founding year is 1995
